These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34817840)

  • 1. Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection.
    Fodor E; Müller V; Iványi Z; Berki T; Kuten Pella O; Hornyák I; Ambrus M; Sárkány Á; Skázel Á; Madár Á; Kardos D; Kemenesi G; Földes F; Nagy S; Matusovits A; János N; Tordai A; Jakab F; Lacza Z
    Infect Dis Ther; 2022 Feb; 11(1):293-304. PubMed ID: 34817840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study.
    Alsharidah S; Ayed M; Ameen RM; Alhuraish F; Rouheldeen NA; Alshammari FR; Embaireeg A; Almelahi M; Adel M; Dawoud ME; Aljasmi MA; Alshammari N; Alsaeedi A; Al-Adsani W; Arian H; Awad H; Alenezi HA; Alzafiri A; Gouda EF; Almehanna M; Alqahtani S; Alshammari A; Askar MZ
    Int J Infect Dis; 2021 Feb; 103():439-446. PubMed ID: 33285283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of SARS-CoV-2 antibody responses pre-COVID-19 and post-COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case-control study.
    Klein MN; Wang EW; Zimand P; Beauchamp H; Donis C; Ward MD; Martinez-Hernandez A; Tabatabai A; Baddley JW; Bloch EM; Mullins KE; Fontaine MJ
    J Clin Pathol; 2022 Aug; 75(8):564-571. PubMed ID: 33893156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convalescent plasma in hospitalized pediatric and obstetric coronavirus disease 2019 (COVID-19) patients.
    Ikeda S; Benzi E; Hensch LA; Devaraj S; Hui SR; Gandhi M; Fox KA; Teruya J; Munoz FM
    Pediatr Int; 2022 Jan; 64(1):e15407. PubMed ID: 36326636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of COVID-19 Patients with Two Units of Convalescent Plasma in a Resource-Constrained State.
    Ipe TS; Ugwumba B; Spencer HJ; Le T; Ridenour T; Armitage J; Ryan S; Pearson S; Kothari A; Patil N; Dare R; Crescencio JCR; Venkata A; Laudadio J; Mohammad K; Jamal N; Thompson J; McNew H; Gibbs M; Hennigan S; Kellar S; Reitzel K; Walser BE; Novak A; Quinn B
    Lab Med; 2022 Nov; 53(6):623-628. PubMed ID: 35771890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients-An Open-Label Phase II Clinical Trial.
    Grubovic Rastvorceva RM; Useini S; Stevanovic M; Demiri I; Petkovic E; Franchini M; Focosi D
    Life (Basel); 2022 Oct; 12(10):. PubMed ID: 36295001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-institutional experience with COVID-19 convalescent plasma in children.
    Jacquot C; Gordon O; Noland D; Donowitz JR; Levy E; Jain S; Willis Z; Rimland C; Loi M; Arrieta A; Annen K; Drapeau N; Osborne S; Ardura MI; Arora S; Zivick E; Delaney M
    Transfusion; 2023 May; 63(5):918-924. PubMed ID: 36965173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment.
    Karaba AH; Johnston TS; Beck E; Laeyendecker O; Cox AL; Klein SL; Sullivan DJ;
    mBio; 2023 Feb; 14(1):e0328722. PubMed ID: 36625657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
    Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
    Trials; 2021 May; 22(1):342. PubMed ID: 34001174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of early transfusion of convalescent plasma with high-titer SARS-CoV-2 neutralizing antibodies in hospitalized patients with COVID-19.
    Sanz C; Nomdedeu M; Pereira A; Sauleda S; Alonso R; Bes M; Brillembourg H; García-Vidal C; Millan A; Martínez-Llonch N; Pirón M; Puerta-Alcalde P; Puig L; Rico V; Soriano A
    Transfusion; 2022 May; 62(5):974-981. PubMed ID: 35338710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-center matched cohort study of convalescent plasma for hospitalized patients with COVID-19.
    Zhou CK; Bennett MM; Villa CH; Hammonds KP; Lu Y; Ettlinger J; Priest EL; Gottlieb RL; Davis S; Mays E; Clarke TC; Shoaibi A; Wong HL; Anderson SA; Kelly RJ
    PLoS One; 2022; 17(8):e0273223. PubMed ID: 35980913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multicenter, Prospective, Observational, Cohort-Controlled Study of Clinical Outcomes Following Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Therapy in Hospitalized Patients With COVID-19.
    Chauhan L; Pattee J; Ford J; Thomas C; Lesteberg K; Richards E; Bernas CA; Loi M; Dumont L; Annen K; Berg M; Zirbes M; Knight V; Miller A; Jenkins TC; Bennett TD; Monkowski D; Boxer RS; Beckham JD
    Clin Infect Dis; 2022 Aug; 75(1):e466-e472. PubMed ID: 34549274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammation.
    Van Rompay KKA; Olstad KJ; Sammak RL; Dutra J; Watanabe JK; Usachenko JL; Immareddy R; Roh JW; Verma A; Shaan Lakshmanappa Y; Schmidt BA; Di Germanio C; Rizvi N; Stone M; Simmons G; Dumont LJ; Allen AM; Lockwood S; Pollard RE; de Assis RR; Yee JL; Nham PB; Ardeshir A; Deere JD; Patterson J; Jain A; Felgner PL; Iyer SS; Hartigan-O'Connor DJ; Busch MP; Reader JR
    bioRxiv; 2021 Sep; ():. PubMed ID: 34494025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study.
    Bartelt LA; Markmann AJ; Nelson B; Keys J; Root H; Henderson HI; Kuruc J; Baker C; Bhowmik DR; Hou YJ; Premkumar L; Cornaby C; Schmitz JL; Weiss S; Park Y; Baric R; de Silva AM; Lachiewicz A; Napravnik S; van Duin D; Margolis DM
    mBio; 2022 Oct; 13(5):e0175122. PubMed ID: 36135380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early high-titer convalescent plasma therapy in patients with moderate and severe COVID-19.
    Fazeli A; Sharifi S; Behdad F; Okati S; Esmaielifar G; Jelveh N; Eshghi P; Mohammadi S
    Transfus Apher Sci; 2022 Apr; 61(2):103321. PubMed ID: 34836825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial.
    Chowdhury FR; Hoque A; Chowdhury FUH; Amin MR; Rahim A; Rahman MM; Yasmin R; Amin MR; Miah MT; Kalam MA; Rahman MS
    Trials; 2020 Oct; 21(1):883. PubMed ID: 33106167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convalescent Plasma the Experience and Journey from Blockbuster to Incognito: A Single Centre Experience.
    Negi G; Kaur D; Jain A; Mohan YK; Meinia SK; Kaur P; Panda PK; Kalita D; Ravikant
    Recent Adv Antiinfect Drug Discov; 2023; 18(3):188-196. PubMed ID: 35733306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID 19 convalescent plasma: Is there still a place for CCP?
    Moog R
    Transfus Apher Sci; 2023 Apr; 62(2):103680. PubMed ID: 36870907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Mortality among COVID-19 ICU Patients after Treatment with HemoClear Convalescent Plasma in Suriname.
    Bihariesingh-Sanchit R; Bansie R; Ramdhani N; Mangroo R; Bustamente D; Diaz E; Fung A Foek C; Thakoer I; Vreden S; Choudhry Z; van 't Wout AB; Diavatopoulos DA; Nierich AP
    mBio; 2023 Apr; 14(2):e0337922. PubMed ID: 36815780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of SARS CoV-2 inpatients treated with convalescent plasma: One-year of data from the Veneto region (Italy) Registry.
    De Silvestro G; Marson P; La Raja M; Cattelan AM; Guarnieri G; Monticelli J; Tiberio I; Vianello A; Gandini G; Gessoni G; Fiorin F; Sardella C; Astolfi L; Saia M;
    Eur J Intern Med; 2022 Mar; 97():42-49. PubMed ID: 34980505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.